Last Updated on October 2, 2024 by The Health Master
Drug alert: Download the list of NSQ samples for July 2023, the link is given below: The Central Drugs Standard Control Organisation (CDSCO) has declared 51 drug samples out of a total of 1306 drug samples tested as not of standard quality (NSQ), none as misbranded, and 3 as spurious during the month of July 2023.
NSQ List is given below the article
Out of the 1306 samples tested during the month, 1252 came out with standard quality, 51 were declared not of standard quality (NSQ), none were declared misbranded, and 3 were declared spurious.
None of the samples were identified as adulterated; however, 3 declared spurious during the month. Every month, the drug regulator comes up with a list of drugs, medical devices, and cosmetics that are declared not of standard quality, spurious, adulterated, or misbranded.
During the month of June 2023, the authorities tested 1273 samples, out of which 1225 were of standard quality. The number of samples declared as not of standard quality was 48, with none being misbranded and one being spurious.
During the month of May 2023, the authorities tested 1302 samples, out of which 1274 were of standard quality. The number of samples declared as not of standard quality was 27, with none being misbranded and one being spurious.
During the month of April 2023, the authorities tested 895 samples, out of which 859 were of standard quality. The number of samples declared as not of standard quality was 35, with none being misbranded and one being spurious.
During the month of March 2023, the authorities tested 1497 samples, out of which 1149 were of standard quality. The number of samples declared as not of standard quality was 48, with none being misbranded or spurious.
During the month of February 2023, the authorities tested 1251 samples, out of which 1192 were of standard quality. The number of samples declared as not of standard quality was 59, with none being misbranded or spurious.
During the month of January 2023, the authorities tested 1348 samples, out of which 1281 were of standard quality. The number of samples declared as not of standard quality was 67, with none being misbranded or spurious.
During the month of December 2022, the authorities tested 1375 samples, out of which 1305 were of standard quality. The number of samples declared as not of standard quality was 70, with none being misbranded or spurious.
During the month of November 2022, the authorities tested 1487 samples, out of which 1404 were of standard quality. The number of samples declared as not of standard quality was 83, with none being misbranded or spurious.
During the month of October 2022, the authorities tested 1280 samples, out of which 1230 were of standard quality. The number of samples declared as not of standard quality was 50, with none being misbranded or spurious.
During the month of September, 2022, the authorities tested 1456 samples, out of which 1397 were of standard quality. The number of samples declared as not of standard quality was 59, with none being misbranded or spurious.
The test samples were drawn by the zonal and sub-zonal offices of CDSCO, and tested in the drug testing laboratories, i.e CDLs, CDTLs, and RDTLs, in Kolkata, Mumbai, Hyderabad, Chandigarh, and Guwahati.
Drug alert: 48 out of 1273 samples declared as NSQ in June 2023
Drug alert: 28 out of 1302 samples declared as NSQ in May 2023
Drug alert: 36 out of 895 samples declared as NSQ in April 2023
Drug alert: 48 out of 1497 samples declared as NSQ in March 2023
Drug alert: 59 out of 1251 samples declared as NSQ in February 2023
Drug alert: 67 out of 1348 samples declared as NSQ in January 2023
Drug alert: 70 out of 1375 samples declared as NSQ in December 2022
Drug alert: 83 out of 1487 samples declared as NSQ in November 2022
Drug alert: 50 out of 1280 samples declared as NSQ in October 2022
Drug alert: 59 out of 1456 samples declared as NSQ in September 2022
Procedure to obtain License to Manufacture drugs for testing and analysis purposes
Procedure to obtain license for Commercial Testing Laboratories
Latest Notifications: Testing Laboratories
Commercial Testing Laboratories
Commercial Testing Laboratories: Procedure
Updated list of Medical Device Testing Laboratories (MDTLs)
List of Laboratory Instruments for Pharma & Cosmetics Industry
Calibration of Laboratory Instruments
NABL: List of NABL Accredited Testing Laboratories
NABL 164 released : Guidelines for Inter-laboratory comparison
NABL releases NABL 136: specific criteria for X-Ray equipment
NABL 126: Specific criteria for calibration of Medical Devices
Major FDA audit findings about Equipment and Instruments
Equipment and Instruments: Maintenance, difference and importance in the Pharma Industry
Quality Assurance in the Pharmaceutical Industry
Upcoming events: Pharma, Cosmetics, Homoeopathy & Medical Devices
Cosmetics Testing in India: A Comprehensive Guide
Difference between Validation and Calibration in the Pharma Industry
Calibration of Laboratory Instruments
Difference: Disintegration and Dissolution test in pharma industry
Understanding DQ, IQ, PQ, and OQ in the Pharma Industry
Duties and responsibilities of QA person in Pharma Industry
Dissolution test: Importance in Pharma Industry
Licensing procedure for manufacturing of Drugs
Procedure to obtain license for manufacturing of Cosmetics
Procedure to obtain license for manufacturing of Homoeopathic Medicines
Procedure to obtain license for manufacturing of Medical Devices
Procedure to obtain License to Manufacture drugs for testing and analysis purposes
Procedure to obtain license for Blood Centre (Blood Bank)
Procedure to obtain license for Commercial Testing Laboratories
USFDA approval granted for Generic Doxepin Hydrochloride Capsules
USFDA issued EIR to Torrent Pharma: Gujarat
Pharmacy Practice Regulations 2015 implemented: Mizoram
Recommendations for expediting TMR for Medical Devices
USFDA gives approval for Guaifenesin ER Tablets
Key Requirements for RTI Orders: High Court’s Directives
Gujarat FDCA: M-Governance soon for Drug Manufacturers and Medical Stores
PIL for Generic Drug Prescription: Supreme Court notice to NMC
Glenmark fined $30 million to resolve drug price-fixing charges
India launches Rs 5,000 Crore R&D Incentive Scheme for Pharma Industry
List of Drugs Declared as Not of Standard Quality/Spurious/Adulterated/Misbranded for the Month of July – 2023.
S.No | Name of Drugs/medical device/cosmetics | Batch No. | Date of Manufacture | Date of Expiry | Manufactured By | Reason for failure | Drawn By | From |
1 | Folic Acid Tablets IP 5mg | T112005 | 05/2022 | 04/2024 | ANG Lifesciences India Ltd., Village Malkumajra, Nalagarh Road, Baddi, Distt. Solan 173205 H.P. | Description & Hydrolysis Products | CDSCO East Zone Kolkata | CDL Kolkata |
2 | Tamsulosin Hydrochloride & Dutasteride Tablets (Urimax D) | GH20067 | 01/2022 | 12/2024 | Cipla Ltd., Verna Indl. Estate, Goa 403722, India | Identification and Assay of Dutasteride and Assay of Tamsulosin Hydrochloride | CDSCO East Zone Kolkata | CDL Kolkata |
3 | Paracin Plus Suspension (Ibuprofen and Paracetamol Suspension) | KCC24A0 02A1A | 04/2023 | 03/2025 | Stadmed Private Limited, 15, Jawpore Road, Kolkata- 700074 | Assay of Ibuprofen and Paracetmol | CDSCO East Zone Kolkata | CDL Kolkata |
4 | Paracin Plus Suspension (Ibuprofen and Paracetamol Suspension) | KCC24A0 01A1A | 04/2023 | 03/2025 | Stadmed Private Limited, 15, Jawpore Road, Kolkata- 700074 | Assay of Ibuprofen and Paracetmol | CDSCO East Zone Kolkata | CDL Kolkata |
5 | Ornidazole & Ofloxacin Tablets IP | HOOZ01 | 07/2022 | 06/2024 | Hindustan Antibiotics Ltd., (A Govt. of India Enterprise) At: 11, W.E.A., Faridabad – 121 001 (Haryana). | Description | CDSCO East Zone Kolkata | CDL Kolkata |
6 | MONZET (Montelukast Sodium and Levocetrizine Hydrochloride Tablets IP) | DMZT- 2205 | 12/2022 | 11/2024 | Kniss Laboratories Pvt. Ltd., No.9, Multe Industrial Estate, Gerugambakkam, Chennai- 600128. | Dissolution | CDSCO East Zone Kolkata | CDL Kolkata |
7 | Lonapam® MD 0.5 (Clonazepam Mouth Dissolving Tablets 0.5 mg) | 43L22T01 | 03/2022 | 02/2025 | Shine Pharmaceuticals Limited, Plot No. 132, Karjan- Vemardi Road, Juni Jitherdi, Ta. Karjan-391240, Dist.: Vadodara (Gujarat) | Related Substances | CDSCO East Zone Kolkata | CDL Kolkata |
8 | Lonapam® MD 0.5 (Clonazepam Mouth Dissolving Tablets 0.5 mg) | 43L23T01 | 02/2023 | 01/2026 | Shine Pharmaceuticals Limited, Plot No. 132, Karjan- Vemardi Road, Juni Jitherdi, Ta. Karjan-391240, Dist.: Vadodara (Gujarat) | Related Substances | CDSCO East Zone Kolkata | CDL Kolkata |
9 | Lonapam® MD 0.5 (Clonazepam Mouth Dissolving Tablets 0.5 mg) | 43L22T03 | 09/2022 | 08/2025 | Shine Pharmaceuticals Limited, Plot No. 132, Karjan- Vemardi Road, Juni Jitherdi, Ta. Karjan-391240, Dist.: Vadodara (Gujarat) | Related Substances | CDSCO East Zone Kolkata | CDL Kolkata |
10 | Maxflux 100 ml (Flucloxacillin Oral solution BP 125mg/5ml) | M481005 | 07/2021 | 06/2023 | Maxheal Pharmaceuticals (India) Ltd., 95/6, M.I.D.C. Satpur, Nashik, Maharashtra 422 007 | Assay of Flucloxacillin | CDSCO West Zone Mumbai | CDL Kolkata |
11 | Maxflux 100 ml (Flucloxacillin Oral solution BP 125mg/5ml) | M481006 | 07/2021 | 06/2023 | Maxheal Pharmaceuticals (India) Ltd., 95/6, M.I.D.C. Satpur, Nashik, Maharashtra 422 007 | Assay of Flucloxacillin | CDSCO West Zone Mumbai | CDL Kolkata |
12 | Neomycin Sulphate Ointment USP 20 gm | 023 | 03/2023 | 02/2025 | Deep Pharma, Unit-2, Survey No. 293/3, Behind Jalaram Mandir, Kalikund Kheda Road, Dholka, Ahmedabad- 382225, Gujarat | Assay of Neomycin | CDSCO Ahmedabad | CDL Kolkata |
13 | PYRITOL (Paracetamol Injection) 2ml | HIPM220 08B | 12/2022 | 11/2024 | Health Biotech Ltd., Village: Sandoli, Nalagarh Road, Baddi, Dist. Solan (HP) India 173205 | Particulate Matter | CDSCO Ahmedabad | CDL Kolkata |
14 | Rabeprazole Gastro-Resistant Tablets IP 20 mg | AT23029 | 02/2023 | 01/2025 | Alves Healthcare Private Limited, Village Nangal Uperla, Swarghat Road, Tehsil, Nalagarh, Dist. Solan – 174101 (H.P.), India | Dissolution | CDSCO Ahmedabad | CDL Kolkata |
15 | SN-15 Plus (Serratiopeptidase & Diclofenac Potassium Tablets) | DS-407 | 10/2022 | 09/2024 | Ruby Organics Pvt. Ltd., D- 79, T.T.C, M.I.D.C, Turbhe, Navi Mumbai-400705. | Disintegration | CDSCO Hyderabad | CDL Kolkata |
16 | Ondansetron Injection IP | L3003 | 11/2022 | 10/2024 | Captab Biotic, Unit-II, Plot No.125, EPIP Road, Mauja Jharmajri, Baddi, Distt. Solan H.P. 173205. | Description and Particulate Matter | Drug Control Department Himachal Pradesh | CDL Kolkata |
17 | Compound Sodium Lactate Injection IP (Ringer Lactate Solution for Injection) RL 500 ml | ODF 221292 | 12/2022 | 11/2024 | Haseeb Pharmaceuticals Pvt. Ltd., Plot No. F 9/14, 15, 16, MIDC, Nagpur-440016. | Particulate Contamination | Drug Control Department Odisha | CDL Kolkata |
18 | Diclofenac Sodium, Paracetamol and Serratiopeptidase Tablets | F23018 | 02/2023 | 01/2026 | Brussels Laboratories Pvt. Ltd., 33, Changodar Ind. Estate, Sarkhej Bavla Road, Changodar – 382210, Ahmedabad, Gujarat. | Assay of Serratiopeptidase | CDSCO Ahmedabad | CDL Kolkata |
19 | Carbamazepine Tablets IP 200 mg | GCB5 | 12/2022 | 11/2024 | Super Formulations Pvt. Ltd., 16-B & 15-F, Industrial Area, Maxi Road, Ujjain (M.P.)-456010. | DISSOLUTION | CDSCO Zonal Office Chennai | CDTL Chennai |
20 | Norfloxacin Tablets IP 400 mg | NRT2300 9 | 01/2023 | 12/2024 | Vivek Pharmachem (India) Ltd.,NH-8, Chimanpura, Amer, Jaipur-303 102. | DISSOLUTION | CDSCO Subzonal Office Bangalore | CDTL Chennai |
21 | Chymovit Forte (Trypsin- Chymotrypsin Tablets) | DMT0027 J | 01/2023 | 12/2024 | DM PHARMA PRIVATE LIMITED., Vill. Bhud, NH- 21A, Baddi, Distt. Solan (H.P.) 173 205 | Uniformity of Weight, Average Weight & Disintegration test (Acid stage) | CDSCO West-Zone Mumbai | CDTL Mumbai |
22 | Trypsin-Chymotrypsin Tablets (Chymnetra-Forte) | DT1624H | 12/2022 | 11/2024 | DM PHARMA PRIVATE LIMITED., Vill. Bhud, NH- 21A, Baddi, Distt. Solan (H.P.) 173 205 | Uniformity of Weight, & Average Weight | CDSCO West-Zone Mumbai | CDTL Mumbai |
23 | Amoxycillin & Potassium Clavulanate Tablets I.P. 625 mg | 422-494A | 03/2022 | 02/2024 | Zee Laboratories Ltd., Behind 47, Industrial Area, Paonta Sahib- 173 025 | Assay | CDSCO West-Zone Mumbai | CDTL Mumbai |
24 | Tropicamide Eye Drops IP 1 % w/v | GTC002 | 05/2022 | 04/2024 | Vivimed Labs Limited., Plot No.8, Phase V, IDA, Jeedimetla, Medchal- Malkajgiri, Dist. Telangana State – 500 055 | Sterility & Assay | CDSCO West-Zone Mumbai | CDTL Mumbai |
25 | Cyproheptadine Hydrochloride Syrup IP (Hungree Syrup) | 30489 | 03/2023 | 02/2025 | Zenith Drugs Pvt. Ltd., 72/5, Muradpura (Orangpura) Dhar Road, Near Kalaria, Indore 453001 (MP) India | pH | CDSCO Indore | CDTL Mumbai |
26 | AMLODIPINE AND ATENOLOL TABLETS IP (ALAMO -AT) | MDG281 K | 11/2022 | 10/2024 | M.R. HEALTHCARE PVT. LTD. Village : Tanda Mallu, Kashipur Road, Ramnagar – 244715, Dist. Nainital, Uttarakhand( INDIA) | Assay of Amlodipine Besilate equivalent to Amlodipine Only | CDSCO Zonal Office Hyderabad | CDTL, HYDERABAD |
27 | ONDANSETRON ORALLY DISINTEGRATING TABLETS IP (ONDAPLUS-MD 4) | GT23030 56B | 03/2023 | 02/2025 | Roseate Medicare., Vill. Anji, Bypass Road, P.O. Barog, Tehsil & Distt. Solan, 173211 (H.P.) INDIA. | Test for Disintegration | CDSCO Zonal Office Hyderabad | CDTL, HYDERABAD |
28 | AMOXYCILLIN AND POTASSIUM CLAVULANATE ORAL SUSPENSION I.P. (TRUECLAM DS) | PM-16064 | 09/2022 | 02/2024 | PERENNIAL MEDICARE, Shamti, Solan-173212 (H.P.) | pH and Assay | CDSCO Zonal Office Hyderabad | CDTL, HYDERABAD |
29 | ALBENDAZOLE TABLETS I.P. 400 mg (FOZY) | RD09- 2202 | 10/2022 | 09/2024 | Vance & Health Pharmaceuticals Pvt. Ltd., Khasra No. 410, Karondi, Roorkee-247 667, Uttarakhand | Test for Dissolution | CDSCO Port Office Visakhapatnam | CDTL, HYDERABAD |
30 | Olmesartan Medoxomil Tablets IP 40 mg | GT22183 1 | 10/2022 | 09/2024 | Theon Pharmaceuticals Ltd., Vill.Saini Majra, Tehsil Nalagarh, Distt. Solan (H.P.) 174101 | Dissolution | CDSCO North Zone | RDTL Chandigarh |
31 | Aluminium Hydroxide (0.291 gm), Magnesium Hydroxide (98 mg) and Oxetacaine (10 mg )Gel | ML22076 1 | 11/2022 | 10/2024 | Mascot Health Series Pvt. Ltd, Plot No. 79,80, Sec-6A, IIE, Sidcul, Haridwar 249403 | Assay of Oxetacaine | CDSCO North Zone | RDTL Chandigarh |
32 | Sodium Valproate and Valproic Acid Controlled Release Tablets 500 mg | 422-2202 | 12/2022 | 11/2024 | ZEE LABORATORIES LTD., Behind 47, Industrial Area, Paonta Sahib-173025 | Identification of Valproic Acid and Assay of Valproic Acid and Sodium Valproate | CDSCO North Zone | RDTL Chandigarh |
33 | Rabeprazole Sodium (Enteric Coated) and Domperidone (Sustained Release) Capsules (20 mg/30 mg) | RPE-2258 | 07/2022 | 06/2024 | Apple Formulations Pvt. Ltd., Plot No. 208, Kishanpur, Roorkee-247667 (U.K.) | Assay of Rabeprazole Sodium | CDSCO North Zone | RDTL Chandigarh |
34 | Itraconazole Capsules 100 mg | Z22-293 | 03/2022 | 02/2024 | Zee Laboratories Ltd., Behind 47, Industrial Area, Paonta Sahib-173025 | Dissolution | CDSCO North Zone | RDTL Chandigarh |
35 | Metformin Hydrochloride Prolonged-release and Glimepiride Tablets IP (Glimipulse M1 Tablets) | SGT- 0624A | 12/2022 | 11/2024 | Saitech Medicare Pvt. Ltd., Village-Kheri, Trilokpur Road, Kala-Amb, Distt. Sirmour, (H.P.) 173030 | Assay of Glimepiride | CDSCO Sub- Zone Baddi | RDTL Chandigarh |
36 | Rosuvastatin Tablets IP (Rosuvas 10 Tablets) | SID3056A | 11/2022 | 04/2025 | Sun pharma laboratories ltd., Plot No. 107-108, Namli Block, P.O. Ranipool, East- Skkim-737135 | Description and Assay of Rosuvastatin Calcium calculated as Rosuvastatin | Drug Control Department Delhi | RDTL Chandigarh |
37 | Nimesulide and Paracetamol Tablets (CDNIM-P TABLETS) | SMP- 2205 | 01/2023 | 12/2024 | Cyper Pharma, K.No. 825- 827, Vill.Gullarwala, Sai Road, Baddi, Distt. Solan (H.P.) 173205 INDIA | Uniformity of weight and Assay of Nimesulide and Paracetamol | Drug Control Department Himachal Pradesh | RDTL Chandigarh |
38 | Calcium Carbonate with Vitamin D3 Tablets (CYPCAL-FORTE TABLETS) | CLF- 22013 | 11/2022 | 10/2024 | CYPER PHARMA, K.No. 825-827, Vill.Gullarwala, Sai Road, Baddi, Tehsil Nalagarh, Distt. Solan (H.P.) 173205 INDIA | Assay of Vitamin D3 | Drug Control Department Himachal Pradesh | RDTL Chandigarh |
39 | Albendazole Tablets IP 400 mg | ABD-2206 | 01/2023 | 12/2024 | CYPER PHARMA, K.No. 825-827, Vill.Gullarwala, Sai Road, Baddi, Tehsil Nalagarh, Distt. Solan (H.P.) 173205 | Dissolution | Drug Control Department Himachal Pradesh | RDTL Chandigarh |
40 | Indomethacin Capsules IP (INDOMETHACIN CAPSULES) | IND-2202 | 02/2023 | 01/2026 | CYPER PHARMA, K.No. 825-827, Vill.Gullarwala, Sai Road, Baddi, Tehsil Nalagarh, Distt. Solan (H.P.) 173205 INDIA | Uniformity of weight and Assay of Indomethacin | Drug Control Department Himachal Pradesh | RDTL Chandigarh |
41 | Griseofulvin Tablets IP 250 mg (Grisowin-250 Tablets) | GSP- 22B08 | 01/2023 | 12/2024 | CYPER PHARMA, K.No. 825-827, Vill.Gullarwala, Sai Road, Baddi, Tehsil Nalagarh, Distt. Solan (H.P.) 173205 (India) | Uniformity of weight and Assay of Griseofulvin | Drug Control Department Himachal Pradesh | RDTL Chandigarh |
42 | Ampicillin Capsules IP (ampicillin Capsules IP-250) | AMP- 22A07 | 01/2023 | 12/2024 | Cyper Pharma, K.No. 825- 827, Vill. Gullarwala, Sai Road, Baddi, Distt. Solan (H.P.) 173205 INDIA | Assay of Ampcillin Trihydrate calculated as Ampicillin | Drug Control Department Himachal Pradesh | RDTL Chandigarh |
43 | Furosemide Tablets IP 40mg (Furosemide-40) | T212721 | 03/2022 | 02/2024 | United Bioceuticals Pvt. Ltd. Plot No. 33C, Industrial Part- IV, Begumpur, Haridwar- 249402 Uttarakhand | Dissolution | Drug Control Department Nagaland | RDTL, Guwahati |
44 | MULTIELECTROLYTE WITH 20% w/v DEXTROSE INJECTION (INTALYTE (Veterinary) | IN703401 1 | 03/2023 | 02/2026 | Abaris Healthcare Pvt. Ltd., Survey No. 1407-11, Village Rajpur, Tal. Kadi. Dist. Mehsana-382740 (Gujarat) | Particulate Contamination, Sterility and Description | Drug Control Department Bihar | RDTL, Guwahati |
45 | Telmisartan Tablets I.P. 40mg. | T101004 | 09/2021 | 08/2023 | ANG Lifesciences India Ltd., Village Malkumajra, Nalagarh Road, Baddi, Distt. Solan- 173205 (H.P.), India | Description | Drug Control Department Bihar | RDTL, Guwahati |
46 | Paraccetamol Tablets I.P. 500 mg | DGT22- 257 | 06/2022 | 05/2024 | ORNATE LABS PVT. LTD. Bela Industrial Estate, Muzaffarpur- 842005 | Dissolution and Assay | Drug Control Department Bihar | RDTL, Guwahati |
47 | DEXADEC INJECTION (Dexamethasone Sodium Phosphate Injection I.P. 2 ml.) | TGL0223 0317 | 02/2023 | 01/2025 | T & G Medicare, Vill. Kunjhal, P.O. Baddi, Dist. Solan, H.P. | Sterility and BET | Drug Control Department Arunachal Pradesh | RDTL, Guwahati |
48 | OFLOXACIN & ORNIDAZOLE TABLETS I.P. (OFNI-OZ) | AT220708 27 | 07/2022 | 06/2024 | Accura Care Pharmaceuticals pvt. Ltd., Vill. Moginand, Nahan Road, Kala Amb. Distt- Sirmour (H.P.) 173030 | Dissolution of Ofloxacin and Ornidazole | CDSCO Sub Zone, Guwahati | RDTL, Guwahati |
S.No | Name of Drugs/medical device/cosmetics | Batch No. | Date of Manufacture | Date of Expiry | Manufactured By | Reason for failure | Drawn By | From | Remarks |
49 | Pantoprazole Gastro- Resistant and Domperidone Prolonged Release Capsules IP (PAN-D) | 23440762 | 03/2023 | 02/2025 | Alkem Health Science, A Unit of Alkem Laboratories Limited, Unit- 2, Samardung, Karek Block, P.O.: Namthang, South Sikkim-737137 | Identification & Assay of Pantoprazole & Domperidone (Sample is deemed to be Spurious) | CDSCO East Zone Kolkata | CDL Kolkata | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. Thus, the product is purported to be spurious, however, the same is subject to outcome of investigation. |
50 | Amoxycillin and Potassium Clavulanate Tablets IP (CLAVAM 625) | 23440774 | 03/2023 | 08/2024 | Alkem Health Science, A Unit of Alkem Laboratories Limited, Unit- 2, Samardung, Karek Block, P.O.: Namthang, South Sikkim-737137 | Identification & Assay of Amoxycillin and Clavulanic Acid (Sample is deemed to be Spurious) | CDSCO East Zone Kolkata | CDL Kolkata | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. Thus, the product is purported to be spurious, however, the same is subject to outcome of investigation. |
51 | Pantoprazole Gastro- resistant Tablets IP (PAN 40) | 23440087 | 01/2023 | 06/2025 | Alkem Health Science, A Unit of Alkem Laboratories Limited, Unit- 2, Samardung, Karek Block, P.O.: Namthang, South Sikkim-737137 | Dissolution | CDSCO East Zone Kolkata | CDL Kolkata | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. Thus, the product is purported to be spurious, however, the same is subject to outcome of investigation. |
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon: